threat
new
reemerg
virus
markedli
increas
recent
decad
due
popul
growth
urban
expans
global
travel
facilit
rapid
spread
infect
past
four
decad
encount
epidem
human
immunodefici
viru
hiv
sever
acut
respiratori
syndrom
sar
middl
east
respiratori
syndrom
mer
coronavirus
pandem
influenza
avian
influenza
virus
ebola
viru
ebov
west
africa
central
africa
zika
viru
zikv
america
initi
identif
contain
outbreak
hinder
occurr
resourcepoor
unavail
diagnost
assay
could
detect
novel
unanticip
viral
strain
lack
prepared
underscor
critic
need
deploy
effect
tool
abl
rapidli
diagnos
emerg
viral
infect
febril
patient
sequenc
genom
inform
public
health
intervent
curb
transmiss
high
sensit
detect
essenti
assay
use
clinic
public
health
set
pcrbase
assay
individu
virus
wide
deploy
diagnost
surveil
applic
due
high
sensit
copi
cp
per
ml
low
howev
assay
limit
requir
priori
knowledg
virus
target
limit
number
target
typic
multiplex
singl
test
primer
use
virusspecif
pcr
assay
also
invari
suffer
sequencesignatur
eros
time
due
genom
diverg
occur
rapidli
rna
virus
encod
errorpron
metagenom
nextgener
sequenc
mng
promis
candid
approach
broadspectrum
pathogen
identif
clinic
sampl
nearli
potenti
pathogen
virus
bacteria
fungi
parasit
detect
uniqu
identifi
dna
andor
rna
shotgun
method
success
appli
clinic
diagnosi
infecti
outbreak
pathogen
requir
priori
target
pathogen
may
suddenli
emerg
new
geograph
region
ebov
west
mng
potenti
use
diagnost
tool
address
unknown
viral
outbreak
howev
issu
relat
cost
sequenc
depth
background
limit
accuraci
mngsbase
diagnost
rel
specif
pcr
test
particular
although
unenrich
mng
use
nanopor
sequenc
use
sequenc
knownposit
virus
clinic
sampl
challeng
use
metagenom
analysi
clinic
sampl
patient
lowtitr
undiagnos
viral
infect
viral
genom
sequenc
essenti
outbreak
manag
enabl
origin
determin
monitor
viral
transmiss
gener
target
enrich
ng
librari
requir
obtain
suffici
viral
genom
coverag
phylogenet
molecular
clock
enrich
librari
use
multiplex
pcr
tile
amplicon
tile
multiplex
pcr
andor
captur
probe
enrich
success
use
genom
surveil
yellow
fever
viru
yfv
tile
multiplex
pcr
usual
target
singl
circul
viral
strain
time
requir
infect
strain
establish
priori
gener
previou
virusspecif
pcr
test
thu
less
practic
virus
exhibit
high
sequenc
diverg
andor
recombin
exampl
hiv
present
compris
multipl
genotyp
exampl
hepat
c
viru
hcv
dengu
denv
larg
panel
contain
million
probe
develop
captur
viral
divers
potenti
enrich
hundr
differ
rel
high
cost
complex
protocol
prolong
turnaround
time
h
hybrid
step
alon
need
effici
captur
probe
hybrid
hinder
broad
applic
approach
method
crosscontamin
seriou
concern
pool
enrich
sampl
togeth
multiplex
hightitr
sampl
commonli
contamin
lowtitr
neg
sampl
sequenc
run
crosscontamin
propos
target
enrich
strategi
term
metagenom
sequenc
spike
primer
enrich
msspe
simpl
lowcost
usd
per
sampl
enrich
viral
read
sequenc
librari
add
extra
time
exist
protocol
yet
retain
breadth
detect
afford
mng
previous
combin
msspe
captur
probe
enrich
recov
wholegenom
sequenc
zikv
infect
patient
central
america
reveal
introduct
viru
brazil
via
hondura
larg
undetect
spread
throughout
region
current
studi
expand
applic
msspe
use
simultan
detect
genom
recoveri
wide
rang
emerg
virus
associ
bloodborn
infect
includ
vectorborn
arboviru
arbov
relat
febril
ill
haemorrhag
fever
also
valid
method
benchtop
illumina
portabl
nanopor
sequenc
platform
use
primari
clinic
sampl
infect
patient
design
short
spike
primer
virus
evalu
current
studi
fig
b
number
primer
per
kilobas
kb
viral
genom
reflect
rel
divers
viru
speci
rang
measl
viru
mev
lassa
viru
lasv
hiv
hcv
respect
supplementari
tabl
first
evalu
enrich
effect
virusspecif
spike
primer
zikv
west
nile
viru
wnv
detect
illumina
miseq
experi
use
either
viral
cultur
supernat
zikv
denv
ebov
hightitr
clinic
sampl
wnv
spike
defin
concentr
neg
plasma
donor
matrix
spike
primer
concentr
maximum
concentr
recommend
specif
degre
zikv
enrich
contriv
sampl
contain
zikv
hcv
offtarget
viru
highest
molar
ratio
spike
random
hexam
rh
primer
supplementari
tabl
minim
loss
detect
sensit
offtarget
hcv
increas
molar
ratio
spike
rh
primer
result
increas
enrich
wnv
read
use
arbov
spike
primer
panel
concentr
supplementari
tabl
spike
primer
target
individu
virus
comparison
concentr
molar
ratio
found
degre
enrich
peak
supplementari
tabl
next
test
spike
primer
concentr
rang
enrich
zikv
denv
ebov
use
spike
primer
panel
detect
arbov
haemorrhag
fever
virus
hfv
virus
combin
combv
peak
perform
arbov
panel
primer
concentr
yield
enrich
zikv
enrich
denv
read
fig
metagenom
detect
offtarget
virus
ebov
impair
optim
primer
concentr
hfv
panel
found
fig
yield
enrich
ebov
combv
panel
optim
primer
concentr
yield
enrich
zikv
denv
ebov
respect
fig
degre
enrich
note
higher
lower
viral
titr
fig
c
next
test
virusspecif
primer
expand
panel
enrich
zikv
denv
ebov
use
optim
concentr
notabl
degre
fold
enrich
zikv
denv
ebov
use
virusspecif
primer
versu
larger
primer
panel
arbov
hfv
combv
compar
fig
e
next
evalu
overal
msspe
enrich
effect
across
virus
pair
mng
run
contriv
clinic
sampl
titr
rang
cp
illumina
miseq
platform
subsequ
sequenc
experi
final
spike
primer
concentr
individu
virus
arbov
panel
combv
panel
hfv
panel
use
mix
rh
primer
ratio
overal
median
fold
enrich
enrich
within
interquartil
rang
iqr
fig
among
contriv
sampl
trend
highest
median
fold
enrich
lowest
titr
median
cp
observ
less
enrich
median
titr
cp
fig
perform
spike
primer
panel
evalu
portabl
minion
nanopor
sequenc
platform
oxford
nanopor
technolog
overal
level
zikv
ebov
denv
enrich
viral
titr
rang
cp
minion
compar
illumina
miseq
median
enrich
respect
supplementari
tabl
use
msspe
enabl
nanopor
illuminabas
metagenom
detect
zikv
ebov
cp
viral
cp
per
complementari
dna
reaction
near
limit
detect
virusspecif
supplementari
tabl
probit
analysi
contriv
sampl
zikv
spike
donor
plasma
matrix
serial
dilut
cp
use
arbov
primer
panel
mean
sequenc
depth
sd
read
yield
analyt
limit
detect
cp
supplementari
tabl
next
evalu
perform
arbov
hfv
panel
portabl
nanopor
sequenc
use
clinic
blood
sampl
patient
infect
chikungunya
viru
chikv
n
denv
n
zikv
n
brazil
ebov
n
democrat
republ
congo
drc
yfv
n
angola
tabl
median
fold
enrich
iqr
observ
across
differ
virus
titr
rang
cp
compar
spike
primer
random
primer
alon
consist
result
use
contriv
sampl
clinic
sampl
lower
viral
titr
cp
produc
robust
enrich
higher
titr
sampl
p
pair
test
fig
evalu
clinic
perform
msspe
test
detect
arbov
zikv
denv
chikv
hfv
yfv
ebov
use
arbov
hfv
primer
panel
respect
also
test
plasma
sampl
infect
patient
parallel
neg
control
sampl
nanopor
sequenc
supplementari
tabl
overal
sensit
specif
posit
predict
valu
neg
predict
valu
assay
respect
supplementari
tabl
three
falseposit
case
attribut
barcod
misassign
demultiplex
sampl
due
nanopor
sequenc
error
supplementari
tabl
crosscontamin
viral
read
observ
either
water
donor
plasma
matrix
sampl
process
sequenc
along
contriv
clinic
sampl
estim
titr
rang
cp
supplementari
tabl
next
test
whether
spike
primer
could
detect
potenti
enrich
sequenc
emerg
flavivirus
clinic
sampl
infect
patient
includ
powassan
viru
powv
usutu
viru
usuv
tabl
notabl
virus
specif
target
priori
initi
spike
primer
design
cerebrospin
fluid
csf
patient
tickborn
powv
meningoenceph
use
arbov
spike
primer
enrich
powv
read
improv
viral
genom
coverag
tabl
fig
align
arbov
spike
primer
powv
genom
access
toler
one
mismatch
identifi
map
genom
supplementari
fig
part
ongo
hiv
genom
surveil
studi
incident
detect
read
map
usuv
plasma
sampl
patient
use
mng
experiment
test
illumina
miseq
limit
throughput
million
raw
read
result
failur
detect
usuv
read
use
rh
primer
alon
versu
detect
six
usuv
read
use
arbov
spike
primer
supplementari
tabl
followup
sequenc
illumina
hiseq
higher
sequenc
depth
million
read
reveal
degre
enrich
usuv
read
use
arbov
panel
tabl
correspond
increas
genom
coverag
spike
primer
arbov
panel
map
usuv
genom
supplementari
fig
assess
whether
metagenom
detect
sensit
offtarget
dna
viral
nonvir
pathogen
retain
use
msspe
evalu
method
use
repres
mixtur
seven
organ
develop
standard
posit
control
clinic
metagenom
assay
normal
read
per
million
rpm
correspond
seven
pathogen
type
compar
use
arbov
hfv
spike
primer
panel
versu
rh
primer
alon
supplementari
tabl
furthermor
msspe
method
enrich
read
correspond
offtarget
virus
associ
laboratori
andor
reagent
contamin
murin
leukaemia
determin
whether
human
host
background
affect
viral
enrich
effect
msspe
compar
proport
human
read
among
clinic
contriv
sampl
vari
level
background
effici
msspe
enrich
decreas
higher
level
background
sinc
robust
enrich
still
observ
csf
brain
tissu
sampl
contain
human
read
supplementari
fig
hypothes
increas
proport
viral
read
obtain
use
msspe
method
would
improv
genom
coverag
msspe
primer
use
enrich
contriv
sampl
zikv
denv
ebov
mev
edmonston
strain
lasv
josiah
strain
sierra
leon
haemorrhag
fever
viru
cchfv
strain
nigeria
spike
donor
plasma
matrix
fig
supplementari
tabl
averag
sd
absolut
percentag
increas
breadth
genom
coverag
dedupl
read
achiev
contriv
sampl
nonseg
virus
use
msspe
rel
rh
primer
supplementari
tabl
segment
cchfv
lasv
virus
msspe
use
virusspecif
spike
primer
improv
genom
coverag
sd
sd
l
segment
lasv
respect
sd
sd
sd
l
segment
cchfv
respect
fig
f
supplementari
tabl
msspe
primer
use
enrich
clinic
sampl
diverg
recombin
strain
cameroon
drc
fig
hcv
genotyp
california
unit
state
fig
zikv
chikv
yfv
denv
ebov
haemorrhag
fever
patient
ebov
boend
outbreak
viral
titr
rang
cp
tabl
clinic
sampl
mean
sd
increas
genom
coverag
use
msspe
also
use
msspe
enrich
jamestown
canyon
viru
jcv
postmortem
brain
tissu
sampl
patient
develop
fatal
viral
enceph
follow
mosquito
bite
virusspecif
enrich
jcv
increas
number
viral
read
versu
enrich
use
zikv
primer
supplementari
tabl
overal
nonseg
virus
increas
genom
coverag
use
msspe
across
contriv
clinic
sampl
sd
calcul
sampl
tabl
supplementari
tabl
despit
robust
fold
enrich
substanti
gain
genom
coverag
observ
clinic
sampl
zikv
ebov
cp
supplementari
tabl
find
attribut
insuffici
sequenc
depth
low
viral
titr
evalu
abil
msspe
discrimin
differ
viral
subtyp
purpos
outbreak
track
test
ten
clinic
sampl
diverg
hiv
hcv
virus
confirm
genotyp
sanger
sequencingbas
assay
supplementari
tabl
ten
sampl
identifi
correct
viral
subtyp
use
msspe
genom
assembl
map
read
averag
depth
rang
suggest
msspe
bia
consensu
genom
assembl
perform
headtohead
comparison
msspe
captur
tile
multiplex
method
enrich
viral
read
zikvposit
clinic
sampl
low
titr
cp
degre
improv
genom
coverag
use
msspe
compar
better
captur
probe
tile
multiplex
pcr
method
howev
crosscontamin
observ
use
tile
multiplex
pcr
captur
probe
enrich
versu
crosscontamin
use
msspe
supplementari
tabl
furthermor
two
method
gener
duplic
read
versu
msspe
supplementari
tabl
tile
multiplex
pcr
zikv
neg
test
contriv
zikv
sampl
contain
prototyp
uganda
strain
probabl
due
sequenc
diverg
american
zikv
strain
outbreak
use
initi
multiplex
pcr
primer
next
evalu
combin
perform
msspe
subsequ
tile
multiplex
pcr
captur
probe
enrich
lowtitr
contriv
clinic
zikv
sampl
cp
use
spike
primer
increas
number
zikv
read
correspond
genom
coverag
averag
compar
rh
primer
alon
use
combin
tile
multiplex
pcr
captur
probe
enrich
supplementari
tabl
fig
notabl
msspe
critic
zikv
genom
recoveri
two
lowtitr
sampl
test
tile
multiplex
pcr
multiplex
pcr
standard
rh
prime
fail
yield
distinct
band
gel
electrophoresi
studi
develop
msspe
univers
robust
target
enrich
method
simpl
low
cost
fast
incur
extra
turnaround
time
compat
differ
librari
prepar
protocol
transposon
adapterlig
base
deploy
benchtop
portabl
sequenc
found
msspe
method
produc
median
enrich
across
differ
virus
lowtitr
clinic
sampl
cp
improv
detect
sensit
cp
increas
mean
genom
coverag
preserv
broad
metagenom
sensit
pathogen
detect
enrich
possibl
across
wide
rang
potenti
target
singl
virus
vari
sequenc
divers
expand
panel
arbov
haemorrhag
fever
inclus
combin
panel
spike
primer
viral
speci
notabl
msspe
demonstr
analyt
limit
detect
genom
cp
zikv
probit
analysi
compar
favour
goldstandard
quantit
pcr
revers
transcript
test
detect
zikv
chikv
denv
ebov
yfv
clinic
sampl
febril
patient
viral
infect
analyt
perform
metric
sensit
specif
posit
predict
valu
neg
predict
valu
taken
togeth
result
demonstr
util
msspe
method
simultan
viral
diagnosi
genom
recoveri
metagenom
surveil
laboratori
field
set
comparison
ng
enrich
strategi
tile
multiplex
pcr
captur
probe
enrich
found
msspe
less
bias
amplif
duplic
read
versu
method
less
sampl
crosscontamin
particular
minim
crosscontamin
observ
msspe
test
contriv
clinic
sampl
viru
titr
rang
cp
nevertheless
msspe
complementari
strategi
increas
yield
viral
read
detect
genom
recoveri
use
combin
altern
approach
pathogen
enrich
mng
librari
use
host
deplet
method
method
includ
differenti
remov
abund
human
ribosom
mitochondri
rna
sequenc
use
antibodi
hybrid
deplet
abund
sequenc
hybrid
dash
nucleas
treatment
asid
postextract
dnase
step
incorpor
host
deplet
part
msspe
given
method
cumbersom
addit
step
difficult
standard
furthermor
host
deplet
method
bia
detect
toward
specif
pathogen
type
enrich
bacteria
fungi
cell
wall
differenti
encapsid
virus
preextract
nucleas
host
deplet
also
perform
rna
level
use
nonhuman
primer
bia
abund
human
host
ribosom
andor
mitochondri
method
primarili
appli
sampl
cellular
lysat
throat
swab
contain
signific
amount
human
ribosom
rna
cellfre
fluid
clinic
plasma
csf
serum
sampl
analys
lower
proport
human
ribosom
rna
make
method
less
effect
impact
nonhuman
primer
proport
contamin
sequenc
metagenom
detect
sensit
nonvir
pathogen
also
unknown
enrich
virus
unknown
clinic
sampl
develop
spike
primer
panel
detect
virus
associ
arbov
infect
haemorrhag
fever
use
custom
spike
primer
panel
allow
rna
viral
pathogen
associ
geograph
region
target
exampl
hfv
test
drc
arbov
test
brazil
futur
region
public
health
surveil
data
leverag
composit
realtim
updat
spike
primer
panel
target
activ
circul
pathogen
especi
import
facilit
rapid
develop
diagnost
test
viral
pathogen
newli
introduc
geograph
region
exampl
ebov
west
africa
zikv
brazil
note
shown
detect
enrich
unexpect
reemerg
andor
coinfect
virus
usuv
powv
possibl
msspe
even
virus
specif
target
priori
enrich
due
conserv
flavivir
primer
arbov
panel
exhibit
incident
sequenc
homolog
offtarget
virus
averag
genom
recoveri
eight
differ
virus
use
virusspecif
spike
primer
expand
panel
improv
minimum
threshold
propos
complet
draft
viral
genom
ref
percentag
sampl
coverag
increas
use
mng
alon
use
msspe
primer
p
mcnemar
pair
twosid
test
previous
publish
simul
analys
undertaken
context
zikv
genom
epidemiolog
central
america
show
genom
coverag
suffici
phylogenet
analysi
accur
determin
viral
lineag
supplementari
fig
ref
notabl
msspe
method
effect
genom
sequenc
recombin
hiv
virus
circul
unknown
recombin
exhibit
sequenc
diverg
env
well
multipl
hcv
genotyp
diverg
lasv
cchfv
virus
robust
improv
genom
coverag
also
observ
test
clinic
sampl
yfv
chikv
denv
portabl
nanopor
sequenc
underscor
potenti
util
msspe
rapid
detect
monitor
viru
outbreak
studi
limit
first
test
respiratori
virus
outbreak
import
coronavirus
enteroviru
ref
influenza
virus
given
success
rna
virus
test
date
like
msspe
method
work
similar
way
addit
rna
virus
second
formal
test
msspe
doublestrand
rna
virus
dna
virus
nonvir
pathogen
third
degre
enrich
msspe
vari
among
differ
virus
rang
similar
rang
observ
previou
largepanel
captur
probe
enrich
vari
enrich
across
differ
sampl
concentr
probabl
due
sever
factor
includ
number
spike
primer
viral
titr
sampl
divers
viral
target
fourth
variabl
level
enrich
coverag
given
nucleotid
posit
achiev
use
msspe
might
preclud
highfidel
viral
quasispeci
analysi
wholegenom
assembl
high
coverag
depth
especi
nanopor
sequenc
given
current
sequenc
error
rate
ref
applic
msspe
may
synergist
complementari
tile
multiplex
pcr
captur
probe
enrich
approach
demonstr
clinic
zikv
serum
sampl
mexico
collect
part
nation
epidemiolog
surveil
programm
instituto
mexicano
del
seguro
social
imss
branch
ministri
health
previous
sampl
ancillari
clinic
epidemiolog
data
deidentifi
analysi
thu
consid
exempt
human
subject
regul
waiver
inform
consent
accord
cfr
b
us
depart
health
human
servic
analysi
whole
blood
sampl
patient
ebov
diseas
approv
ministri
health
drc
patient
boend
ebov
outbreak
august
septemb
provid
oral
consent
studi
enrol
collect
analysi
blood
consent
obtain
home
patient
hospit
isol
ward
team
includ
staff
member
ministri
health
plasma
sampl
patient
andor
usuv
infect
provid
abbott
global
surveil
program
briefli
inform
consent
obtain
collect
infect
blood
donat
blood
bank
cameroon
analysi
viral
load
determin
sequenc
protocol
approv
local
ethic
clinic
sampl
analys
univers
california
san
francisco
ucsf
protocol
approv
ucsf
institut
review
board
protocol
viral
cultur
zikv
uganda
strain
denv
type
bacteriophag
purchas
american
type
cultur
collect
atcc
ebola
cultur
kikwit
strain
trizol
ls
thermo
fisher
scientif
provid
j
patterson
texa
biomed
research
institut
donor
plasma
matrix
consist
pool
plasma
multipl
deidentifi
blood
donor
test
neg
infect
bloodborn
pathogen
includ
hiv
hbv
hcv
treponema
pallidum
obtain
golden
west
biolog
inc
clinic
zikv
serum
sampl
provid
central
laboratori
epidemiolog
cle
imss
mexico
citi
mexico
blood
system
research
institut
forward
revers
primer
zikv
zikv
respect
carboxyfluorescein
fam
label
probe
zikv
use
previous
clinic
chikv
denv
sampl
febril
return
travel
provid
california
depart
public
health
clinic
ebola
sampl
collect
patient
boend
outbreak
provid
inrb
kinshasa
drc
realtim
test
use
determin
viral
titr
zikv
ref
denv
ebov
standard
curv
analysi
supplementari
tabl
clinic
hiv
hepat
c
plasma
sampl
obtain
ucsf
clinic
microbiolog
laboratori
san
francisco
usa
clinic
sampl
hivinfect
patient
cameroon
provid
univers
yaound
bamenda
montang
cameroon
abbott
laboratori
inc
clinic
yellow
fever
sampl
collect
patient
yellow
fever
outbreak
angola
provid
angolan
nation
institut
public
health
csf
sampl
patient
powv
meningoenceph
provid
boston
children
hospit
postmortem
brain
biopsi
tissu
patient
die
jcv
enceph
provid
massachussett
gener
hospit
posit
control
seven
organ
obtain
ucsf
clinic
microbiolog
laboratori
repres
mixtur
seven
organ
includ
rna
viru
hiv
dna
viru
cytomegaloviru
gramposit
bacterium
streptococcu
agalactia
gramneg
bacterium
klebsiella
pneumonia
yeast
cryptococcu
neoforman
mould
aspergillu
niger
parasit
toxoplasma
gondii
sought
develop
gener
method
combin
metagenom
viral
detect
enrich
genom
recoveri
clinic
sampl
requir
method
applic
target
virus
vari
number
refer
genomesgenom
segment
databas
exampl
fig
preserv
broad
metagenom
sensit
comprehens
detect
offtarget
virus
andor
viral
coinfect
impact
turnaround
time
sampl
process
enrich
mng
librari
suffici
allow
robust
viral
genom
recoveri
lowtitr
clinic
sampl
specif
design
autom
comput
algorithm
took
arbitrari
set
refer
genom
input
construct
minim
panel
short
spike
primer
cover
genom
fig
ad
cdna
synthesi
revers
transcript
step
mng
librari
prepar
fig
design
specif
spike
primer
viru
multipl
sequenc
align
complet
viral
genom
download
nation
center
biotechnolog
inform
ncbi
genbank
nucleotid
databas
septemb
perform
use
multipl
align
use
fast
fourier
transform
mafft
default
paramet
algorithm
auto
score
matrix
gap
open
penalti
offset
valu
inhous
bioinformat
pipelin
name
msspedesign
develop
ubuntu
linux
comput
server
autom
design
spike
primer
briefli
multipl
sequenc
alignmentalign
genom
partit
overlap
segment
overlap
use
pyfasta
http
pypipythonorgpypipyfasta
forward
revers
primer
select
region
end
segment
iter
rank
candid
kmer
sequenc
revers
order
frequenc
select
top
kmer
share
segment
contain
ambigu
nucleotid
remov
segment
share
repeat
process
remain
segment
decreas
overal
spike
primer
cost
iter
repeat
number
remain
segment
contain
share
kmer
predesign
threshold
rang
n
virus
limit
number
genomesgenom
segment
cchfv
n
virus
compris
thousand
genom
multipl
genotyp
denv
spike
primer
filter
remov
primer
melt
temperatur
greater
sd
mean
predict
selfdimer
crossdimer
valu
standard
free
energi
dna
duplex
format
equal
neg
kcal
spike
primer
synthes
integr
dna
technolog
inc
forward
revers
spike
primer
oligonucleotid
target
individu
virus
synthes
nmol
scale
plate
standard
desalt
nmol
individu
oligonucleotid
mix
resuspend
final
volum
idt
ph
spike
primer
panel
arbov
hfv
combv
design
mix
spike
primer
individu
viru
equimolar
ratio
dilut
buffer
desir
concentr
estim
cost
per
sampl
million
read
use
illumina
miseq
approxim
us
random
metagenom
sequenc
tenfold
viral
read
approxim
million
raw
sequenc
read
need
estim
cost
us
per
sampl
use
illumina
hiseq
platform
comparison
msspe
approach
obtain
averag
viral
enrich
low
increment
cost
us
per
sampl
use
individu
virusspecif
primer
us
use
spike
primer
panel
supplementari
tabl
minim
sampl
exogen
laboratori
crosscontamin
librari
prepar
strict
measur
implement
includ
unidirect
workflow
separ
prepcr
postpcr
workspac
use
differ
room
rigor
decontamin
biosafeti
cabinet
work
bench
use
bleach
andor
ethanol
potenti
contamin
monitor
process
neg
water
donor
plasma
matrix
control
parallel
sampl
subset
run
prepar
metagenom
sequenc
librari
viral
rna
first
extract
contriv
clinic
patient
sampl
use
advanc
xl
biorobot
viru
mini
kit
qiagen
except
ebov
rna
extract
manual
viral
haemorrhag
fever
refer
laboratori
inrb
kinshasa
use
directzol
rna
miniprep
kit
zymo
research
final
rna
elut
ave
buffer
nucleic
acid
extract
treat
dnase
turbo
dnase
baselin
turbo
buffer
nucleasefre
water
incub
eppendorf
thermomix
rpm
min
zymo
rna
clean
concentr
kit
zymo
research
use
clean
dnasetr
rna
final
rna
elut
water
rna
mix
rh
alon
spike
primer
plu
rh
ratio
spike
primer
rh
heat
min
revers
transcript
master
mix
superscript
iii
buffer
dntp
mm
dtt
superscript
iii
enzym
ad
sampl
incub
min
follow
min
min
cool
secondstrand
synthesi
master
mix
sequenas
buffer
sequenas
enzym
water
ad
reaction
follow
slow
min
ramp
incub
result
cdna
clean
use
zymo
dna
clean
concentr
kit
zymo
research
addit
linear
acrylamid
sampl
elut
water
use
illumina
nextera
xt
kit
sampl
cdna
incub
min
tagment
mix
td
buffer
atm
enzym
immedi
neutral
nt
buffer
tagment
dna
transfer
reaction
tube
contain
index
mix
nextera
xt
pcr
master
mix
primer
primer
illumina
barcod
individu
sampl
pcr
amplif
perform
use
follow
condit
initi
denatur
step
follow
cycl
denatur
anneal
extens
final
extens
min
pcr
pcr
product
analys
gel
electrophoresi
check
librari
size
band
intens
band
faint
band
observ
gel
anoth
round
recoveri
pcr
perform
recoveri
pcr
librari
wash
use
ampur
xt
bead
beckman
coulter
clean
librari
mix
master
mix
buffer
nextera
gener
primer
forward
revers
dntp
phusion
dna
polymeras
enzym
water
follow
incub
cycl
pcr
denatur
anneal
extens
final
extens
min
final
cdna
librari
elut
eb
buffer
wash
step
use
ampur
bead
cdna
librari
quantifi
use
qubit
fluoromet
thermo
fisher
scientif
size
librari
measur
use
agil
bioanalyz
agil
technolog
sampl
mix
pool
togeth
final
multiplex
librari
quantifi
use
qubit
fluoromet
illumina
sequenc
perform
miseq
instrument
use
singleend
run
accord
manufactur
protocol
nanopor
sequenc
three
five
individu
barcod
cdna
nextera
librari
mix
equimolar
amount
final
mix
contain
ng
dna
dna
endrepair
ligat
adapt
motor
protein
use
ligat
sequenc
kit
oxford
nanopor
technolog
nanopor
sequenc
metagenom
librari
run
flow
cell
use
either
minion
gridion
instrument
oxford
nanopor
technolog
five
barcod
sampl
librari
prepar
use
ligat
sequenc
kit
oxford
nanopor
technolog
quantifi
pool
togeth
ident
fashion
illumina
nextera
librari
load
singl
flow
cell
sequenc
xgen
lockdown
kit
idt
technolog
use
captur
probe
enrich
zikv
briefli
barcod
amplifi
cdna
librari
correspond
sampl
mix
equimolar
proport
gener
pool
librari
pool
librari
ad
hybrid
mix
contain
zikv
xgen
lockdown
probe
hybrid
reaction
perform
incub
h
follow
streptavidin
bead
captur
min
bead
contain
captur
cdna
resuspend
amplif
reaction
mix
kapa
hifi
hotstart
readymix
xgen
primer
water
postcaptur
pcr
perform
follow
cycl
denatur
anneal
extens
final
extens
min
pcr
amplicon
purifi
use
volum
ampur
xp
bead
final
elut
eb
buffer
purifi
pcr
product
analys
gel
electrophoresi
check
librari
size
dna
concentr
estim
use
qubit
fluoromet
captur
probe
enrich
librari
run
illumina
miseq
instrument
use
singleend
run
accord
manufactur
protocol
tile
multiplex
pcr
zikv
enrich
perform
accord
primal
protocol
describ
ref
except
librari
prepar
use
msspe
tile
multiplex
pcr
ampur
bead
wash
perform
immedi
cdna
synthesi
ad
multiplex
primer
remov
residu
zikv
msspe
primer
ad
revers
transcript
step
visual
pcr
band
expect
size
nucleotid
gel
electrophoresi
barcod
sequenc
librari
prepar
use
nebnext
ultra
ii
dna
librari
prepar
kit
new
england
biolab
inc
sequenc
illumina
miseq
instrument
use
pairedend
run
accord
manufactur
protocol
sequenc
data
illumina
miseq
hiseq
instrument
analys
virus
use
sequencebas
ultrarapid
pathogen
identif
surpi
comput
pipelin
ucsf
modifi
version
previous
publish
bioinformat
analysi
pipelin
pathogen
identif
mng
sequenc
specif
surpi
pipelin
modif
includ
updat
refer
databas
base
ncbi
nucleotid
databas
march
build
filter
algorithm
exclus
falseposit
hit
databas
misannot
taxonom
classif
specieslevel
identif
surpi
identif
viral
read
viral
read
trim
nucleotid
end
remov
spike
primer
map
close
match
refer
genom
visual
use
geneiou
ref
duplic
viral
read
remov
use
prinseq
paramet
genom
map
assembl
estim
percentag
human
read
human
background
clinic
sampl
contriv
sampl
spike
donor
plasma
matrix
illumina
preprocess
read
align
human
refer
genom
access
proport
human
read
determin
use
surpi
pipelin
nanopor
sequenc
run
either
minion
gridion
instrument
nanopor
raw
file
basecal
use
albacor
minion
guppi
gridion
realtim
mode
without
polish
viru
detect
nanopor
read
use
pipelin
develop
inhous
call
surpi
real
time
surpirt
briefli
multiplex
sampl
fastq
file
first
comput
separ
barcod
follow
preprocess
trim
adapt
lowcomplex
sequenc
partit
first
nucleotid
preprocess
nanopor
read
three
segment
viral
read
identifi
use
bowti
ref
align
minimum
align
score
cutoff
filter
taxonom
classif
algorithm
appli
describ
viral
read
trim
nucleotid
end
remov
spike
primer
pcr
duplic
read
remov
map
close
match
refer
genom
use
graphmap
visual
use
geneiou
illumina
sequenc
rpm
metric
calcul
number
viral
speciesspecif
read
divid
number
preprocess
read
trim
lowqual
filter
lowcomplex
filter
raw
read
million
nanopor
sequenc
rpm
calcul
number
viral
speciesspecif
read
divid
number
basecal
read
million
enrich
defin
rpm
obtain
target
viru
use
msspe
divid
rpm
obtain
use
rh
prime
median
fold
chang
iqr
given
nonnorm
distribut
data
percentag
increas
genom
coverag
genom
coverag
obtain
use
rh
alon
subtract
obtain
use
msspe
mcnemar
pair
test
use
compar
two
proport
pair
condit
use
msspe
p
valu
less
consid
statist
signific
pair
test
use
compar
mean
fold
enrich
group
p
valu
less
consid
statist
signific
probit
analysi
determin
limit
detect
perform
use
statplu
softwar
analystsoft
inc
comparison
use
spike
primer
random
primer
normal
across
barcod
run
perform
randomli
select
subset
preprocess
read
size
fix
run
fewest
number
read
determin
number
viral
read
within
equal
size
subset
preprocess
read
tabul
viral
read
subset
use
downstream
genom
assembl
inform
research
design
avail
natur
research
report
summari
link
articl
